Treatment Developed By Texas A&M Biologists Shows Promise In Fighting Fibrotic Disease
Texas A&M UniversityA decade after first identifying serum amyloid P (SAP) as a key protein in human blood that controls routine tissue-related processes from scarring to healing, two Texas A&M University scientists continue to make encouraging progress in the fight against fibrotic disease.